The Centre for Commercialization of Regenerative Medicine (CCRM) Australia again partners with local and international venture capital firms to hold a second National Regenerative Medicine SuperPitch. The SuperPitch
Authors: Bhavi Kadakia, Dharvi Patel, Harmanpreet Harmanpreet, Mahmuda Khatun Edited by: Dr Chih Wei Teng CCRM Australia offers various programs designed to support the development of the Australian
Author: Dr Chih Wei Teng The world waits in bated breath for a COVID-19 vaccine as numerous countries remain locked down in varying degrees. At the time of
CCRM Australia, in collaboration with BioMelbourne Network, will be delivering a series of stand-alone webinars focusing on the regenerative medicine industry. Comprising presentations from both local and international
The Centre for Commercialization of Regenerative Medicine (CCRM) Australia has partnered with local and international venture capital firms to launch the National Regenerative Medicine SuperPitch. The SuperPitch offers expertise and
Author: Ali Ranjbaran, Editor: Dr Chih Wei Teng Progress in medical science has always been driven by the need to overcome challenges and new threats to public health.
Regenerative Medicine: Impacts and lessons from COVID-19 Date: Thursday, 14th May 2020 Time: 12noon to 1pm AEST The effects of COVID-19 have been far reaching with negative impacts
The CCRM Australia team is modifying how we work and how we engage with those around us due to the evolving COVID-19 situation. We are well prepared to
CCRM Australia looks to the new decade with Australia as part of a worldwide regenerative medicine network without borders The coming decade is likely to bring significant advances
How CCRM Australia’s academic and industry partnerships helped an industry innovator connect with academic expertise and resources to deliver commercial-scale cell manufacturing. About Cynata Cynata is an Australian
